WDFY3 and ovarian cancer: Recent investigation unveiled that WDFY3‐AS2 suppressed ovarian cancer progression by sponging miR‐18a20 and WDFY3‐AS2 may be a novel valuable prognostic factor for the patients with diffuse glioma.21